𝔖 Bobbio Scriptorium
✦   LIBER   ✦

184 Histone deacetylase inhibitor Belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth hormone refractory models

✍ Scribed by C. Festuccia; G.L. Gravina; F. Marampon; L.A. Biordi; E. Ricevuto; C. Ficorella; V. Tombolini


Book ID
119602865
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
64 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.